$BRQL
brooqLy, Inc.

2022 Q3 Form 10-Q Financial Statement

#000147793222005922 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $201.00 $661.00
YoY Change -81.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $142.6K $49.59K
YoY Change 133.36% 78.85%
Operating Profit -$142.4K -$48.93K
YoY Change 137.38% 76.46%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $48.00
YoY Change -100.04%
Pretax Income -$142.3K -$48.93K
YoY Change -20.91% 76.46%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$142.3K -$48.93K
YoY Change 137.3% 76.46%
Net Earnings / Revenue -70816.92% -7401.82%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 23.31M shares 21.69M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.328K $5.543K $30.04K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $204.00 $204.00
Receivables
Other Receivables
Total Short-Term Assets $1.532K $30.24K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $139.0K $49.26K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.532K $30.24K
Total Long-Term Assets $139.0K $49.26K
Total Assets $140.5K $79.50K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $64.80K $16.21K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $97.98K $21.81K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $97.98K $21.81K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$547.3K -$404.9K -$289.3K
YoY Change
Common Stock $2.232K $2.257K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.51K $10.05K $57.69K
YoY Change
Total Liabilities & Shareholders Equity $140.5K $76.90K $79.50K
YoY Change

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income -$142.3K -$48.93K
YoY Change 137.3% 76.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001854526
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22564982 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22089982 shares
CY2022Q2 brooqly Common Stock Share Outstanding
CommonStockShareOutstanding
22089982 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56399
dei Entity Registrant Name
EntityRegistrantName
brooqLy, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2265420
dei Entity Address Address Line1
EntityAddressAddressLine1
10101 S. Roberts Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 209
dei Entity Address City Or Town
EntityAddressCityOrTown
Palos Hill
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60465
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
661 usd
CY2022Q2 us-gaap Revenues
Revenues
661 usd
CY2021Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
19492 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
6622 usd
CY2022Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
30095 usd
CY2021Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
21104 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27726 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48926 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27726 usd
dei City Area Code
CityAreaCode
224
dei Local Phone Number
LocalPhoneNumber
789-6673
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23314982 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22564982 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10049 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-27726 usd
us-gaap Net Income Loss
NetIncomeLoss
-115638 usd
us-gaap Net Income Loss
NetIncomeLoss
-32651 usd
CY2022Q2 brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2021Q2 brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.01
brooqly Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2022Q2 brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
22019652 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4925 usd
CY2021Q2 brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
19862967 shares
brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
22121612 shares
brooqly Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
9931484 shares
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1131 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21839 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8802 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
4975 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18874 usd
brooqly Payment To Software
PaymentToSoftware
23028 usd
brooqly Payment To Software
PaymentToSoftware
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
brooqly Shares Issued For Cash
SharesIssuedForCash
68000 usd
brooqly Shares Issued For Cash
SharesIssuedForCash
25400 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
68000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25400 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-24492 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6526 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30035 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5543 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6526 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57687 usd
CY2022Q1 brooqly Shares Issued For Cash Amount
SharesIssuedForCashAmount
12999 usd
CY2022Q1 brooqly Reversal Of Warrants Amount
ReversalOfWarrantsAmount
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-66712 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3975 usd
CY2022Q2 brooqly Shares Issued For Cash Amount
SharesIssuedForCashAmount
55000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-48926 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10049 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-27726 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-7251 usd
CY2022Q1 brooqly Cancellation Of Common Stock And Warrants
CancellationOfCommonStockAndWarrants
1000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
22564982 shares
CY2022Q1 brooqly Payment Made To Investor
PaymentMadeToInvestor
75000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
776 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 brooqly Common Stock Share Issued
CommonStockShareIssued
22089982 shares
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
265500 usd
CY2021 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
247482 shares
CY2022Q1 brooqly Warrants Issued To Accredited Investor
WarrantsIssuedToAccreditedInvestor
1000000 shares
CY2022Q1 brooqly Purchase Of Common Stock
PurchaseOfCommonStock
1000000 shares
CY2022Q1 brooqly Purchase Of Warrants During Period
PurchaseOfWarrantsDuringPeriod
1000000 shares
CY2022Q1 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
0.10
CY2022Q1 brooqly Desription Of Investment
DesriptionOfInvestment
The investment was in excess of $50,000 entitling the investor to receive shares and warrants at a reduced price instead of at $0.20 per share from those investors investing less than $50,000. The investor failed to pay $75,000 of the aggregate investment and the company has determined that the investor will not receive the benefit of the $0.10 per share price and its shares shall be calculated on the basis of $0.20 per share, for which there is an adjusted number of common shares (and no warrants), of 125,000 shares for the cash proceeds of $25,000 that the company received from the investor.
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
525000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
80000 usd
brooqly Stock Issued For Exercise Of Warrants
StockIssuedForExerciseOfWarrants
350000 shares
brooqly Proceeds From Stock Issued For Exercise Of Warrants
ProceedsFromStockIssuedForExerciseOfWarrants
35000 usd
CY2021Q4 brooqly Number Of Investors
NumberOfInvestors
3 integer
CY2022Q1 brooqly Desription Of Investment
DesriptionOfInvestment
Aggregate Investment; as such, the investment was calculated on the basis of $0.20 per share, for which there is an adjusted number of Common Stock Shares (and no warrants) of 125,000 shares, rather than the 1,000,000 shares. The difference of 875,000 shares (will be cancelled and returned to the Company’s treasury. resulting in a decrease of the Company’s outstanding shares by 875,000 shares
CY2022Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
57688 usd
CY2022Q1 brooqly Cancellation Of Common Stock And Warrants
CancellationOfCommonStockAndWarrants
1000000 shares
CY2022Q1 brooqly Number Of Common Stock Sold
NumberOfCommonStockSold
525000 shares
CY2022Q1 brooqly Receipt From Sale Of Common Stock
ReceiptFromSaleOfCommonStock
80000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115638 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10049 usd
CY2021Q1 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
0 usd
CY2021Q4 brooqly Shares Issued1
SharesIssued1
2564982 shares
CY2021Q4 brooqly Stockholders Equity Note Subscriptions Receivable1
StockholdersEquityNoteSubscriptionsReceivable1
88000 usd
CY2021 brooqly Common Stock For Stock Base Compensation
CommonStockForStockBaseCompensation
247482 shares
CY2021 brooqly Common Stock For Stock Base Compensation Amount
CommonStockForStockBaseCompensationAmount
49497 usd
CY2021Q4 brooqly Outstanding Warrants
OutstandingWarrants
120000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-289309 usd
CY2022Q2 brooqly Operating Gain Loss Carryforwards
OperatingGainLossCarryforwards
-404947 usd
CY2021Q4 brooqly Operating Gain Loss Carryforwards
OperatingGainLossCarryforwards
-289309 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
404947 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
289309 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 brooqly Operating Gain Loss Carryforwards
OperatingGainLossCarryforwards
-289309 usd
CY2022Q2 brooqly Operating Gain Loss Carryforwards
OperatingGainLossCarryforwards
-404947 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22089982 shares
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
412787 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
432740 usd
CY2022Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
0 usd
CY2021Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
88000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-404947 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-289309 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
57687 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76904 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79498 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd

Files In Submission

Name View Source Status
brooqly-20220630_cal.xml Edgar Link unprocessable
0001477932-22-005922-index-headers.html Edgar Link pending
0001477932-22-005922-index.html Edgar Link pending
0001477932-22-005922.txt Edgar Link pending
0001477932-22-005922-xbrl.zip Edgar Link pending
brooqly-20220630.xsd Edgar Link pending
brooqly_10q.htm Edgar Link pending
brooqly_ex311.htm Edgar Link pending
brooqly_ex312.htm Edgar Link pending
brooqly_ex321.htm Edgar Link pending
brooqly_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
brooqly-20220630_def.xml Edgar Link unprocessable
brooqly-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
brooqly-20220630_pre.xml Edgar Link unprocessable
brooqly_10q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending